SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-014002
Filing Date
2021-02-24
Accepted
2021-02-24 19:37:29
Documents
1
Period of Report
2021-02-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 12631
  Complete submission text file 0001209191-21-014002.txt   14019
Mailing Address 120 WEST 45TH STREET 17TH FLOOR NEW YORK NY 10036
Business Address 120 WEST 45TH STREET 17TH FLOOR NEW YORK NY 10036 503-299-1150
Schrodinger, Inc. (Issuer) CIK: 0001490978 (see all company filings)

IRS No.: 954284541 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address SCHRODINGER, INC. 120 WEST 45TH STREET, 17TH FLOOR NEW YORK NY 10036
Business Address
Daniel Jennifer (Reporting) CIK: 0001797725 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39206 | Film No.: 21675770